Skip to main content
SpringerLink
Log in

Angiotensin Converting Enzyme Inhibitors Versus Digoxin for the Treatment of Congestive Heart Failure

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Angiotensin converting enzyme (ACE) inhibition and digoxin may be used in the management of heart failure. Digoxin increases myocardial contractility in vitro, and has a modest but durable beneficial effect in congestive heart failure due to impaired left ventricular systolic function. ACE inhibitors have clear beneficial effects in all grades of heart failure and, in addition, modify the natural history and reduce mortality.

Comparative studies in mild to moderate heart failure reveal a tendency towards greater benefits and tolerability of ACE inhibitors over digoxin.

ACE inhibition is indicated, in conjunction with diuretic therapy, for all grades of heart failure. Digoxin is best reserved for patients with atrial fibrillation and a rapid ventricular response, and for those whose heart failure is not controlled with an ACE inhibitor plus a diuretic.

In patients with heart failure following myocardial infarction, digoxin is of modest benefit. Digoxin should be administered slowly and carefully to avoid acute vasoconstriction and toxicity. Provisional data suggest ACE inhibitors are also beneficial in these patients. However, the results of clinical trials presently in progress are required to clarify their role following myocardial infarction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alderman EL, Glantz SA. Acute hemodynamic interventions shift the diastolic pressure-volume curve in man. Circulation 54: 662–671, 1976

    PubMed  CAS  Google Scholar 

  • Alicandri C, Fariello R, Boni E, Zaninelli A, Muiesan G. Comparison of captopril and digoxin in mild to moderate heart failure. Postgraduate Medical Journal 62 (Suppl. 1): 170–175, 1986

    PubMed  Google Scholar 

  • Alker KJ, Kloner RA. The effect of digitalis on experimental myocardial infarct size and hemodynamics. American Heart Journal 113: 1353–1355, 1987

    PubMed  CAS  Google Scholar 

  • Arnold SB, Byrd RC, Meister W, Melmon K, Cheitlin MD, et al. Long-term digitalis therapy improves left ventricular function in heart failure. New England Journal of Medicine 303: 1443–1448, 1980

    PubMed  CAS  Google Scholar 

  • Aronow WS, Starling L, Etienne F. Lack of efficacy of digoxin in the treatment of compensated congestive heart failure with third heart sound and sinus rhythm in elderly patients receiving diuretic therapy. American Journal of Cardiology 58: 168–169, 1986

    PubMed  CAS  Google Scholar 

  • Askey JM. Digitalis in acute myocardial infarction. Journal of the American Medical Association 146: 1008–1010, 1951

    PubMed  CAS  Google Scholar 

  • Atlas SA, Case DB, Yu ZY, Laragh JH. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril. American Journal of Medicine 77 (Suppl. 2A): 13–17, 1984

    PubMed  CAS  Google Scholar 

  • Bayliss J, Norell MS, Canepa-Anson R, Reid C, Poole-Wilson P, et al. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazoscin. British Medical Journal 290: 1861–1865, 1985

    PubMed  CAS  Google Scholar 

  • Beaune J. Comparison of enalapril versus digoxin for congestive heart failure. American Journal of Cardiology 63 (Suppl. D): 22–25, 1989

    Google Scholar 

  • Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB. Digitalis intoxication. A prospective study with serum level correlations. New England Journal of Medicine 284: 989–997, 1971

    PubMed  CAS  Google Scholar 

  • Bigger JT, Fleiss JL, Rolnitzky LM, Merab JP, Ferrick KJ. Effect of digitalis treatment on survival after acute myocardial infarction. American Journal of Cardiology 55: 623–630, 1985

    PubMed  Google Scholar 

  • Braunwald E, Colucci WS. Vasodilator therapy of heart failure. New England Journal of Medicine 310: 459–461, 1984

    PubMed  CAS  Google Scholar 

  • Bristow MR, Ginsburg R, Minobe BS, Cubicciotti RS, Sageman WS, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. New England Journal of Medicine 307: 205–211, 1982

    PubMed  CAS  Google Scholar 

  • Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Journal of the American College of Cardiology 2: 755–763, 1983

    Google Scholar 

  • Captopril Multicenter Research Group. A cooperative multicentre study of captopril in congestive heart failure: hemodynamic effects and long term response. American Heart Journal 110: 439–447, 1985

    Google Scholar 

  • Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. Journal of the American Medical Association 259:/539-544, 1988

    Google Scholar 

  • Carliner NH, Gilbert CA, Pruitt AW, Goldberg LI. Effects of maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations. Circulation 50: 94–98, 1974

    PubMed  CAS  Google Scholar 

  • Chatterjee K, Rouleau J, Parmley WW. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure. British Heart Journal 50: 233–238, 1982

    Google Scholar 

  • Cleland JGF, Dargie HJ, Hodsman GP, Ball SG, Robertson JIS, et al. Captopril in heart failure a double blind controlled trial. British Heart Journal 52: 530–535, 1984

    PubMed  CAS  Google Scholar 

  • Cody J, Covit A, Schaer G. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure. American Heart Journal 104: 1180–1183, 1982

    PubMed  CAS  Google Scholar 

  • Cody RJ, Franklin KW, Kluger J, Laragh JH. Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. American Journal of Medicine 72: 791–797, 1982

    PubMed  CAS  Google Scholar 

  • Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. New England Journal of Medicine 325: 303–310, 1991

    PubMed  CAS  Google Scholar 

  • Cohn JN, Tristani FE, Khatri IM. Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. American Heart Journal 78: 318–330, 1969

    PubMed  CAS  Google Scholar 

  • Colucci WS, Williams GH, Alexander RW, Braunwald E. Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. American Journal of Medicine 71: 89–99, 1981

    PubMed  CAS  Google Scholar 

  • Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. New England Journal of Medicine 316: 1429–1435, 1987

    Google Scholar 

  • Covell JW, Braunwald E, Ross J, Sonnenblick EH. Studies on digitalis. XVI. Effects on myocardial oxygen consumption. Journal of Clinical Investigation 45: 1535–1542, 1966

    PubMed  CAS  Google Scholar 

  • Cowley AJ, Rowley JM, Stainer K, Hamption JR. Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure. Lancet 2: 1120–1124, 1984

    PubMed  CAS  Google Scholar 

  • Crawford MH, Karliner JS, O’Rourke RA. Favourable effects of oral maintenance digoxin therapy on left ventricular performance in normal subjects: echocardiographic study. American Journal of Cardiology 38: 843–847, 1976

    PubMed  CAS  Google Scholar 

  • Creager MA, Faxon DP, Cutler SS, Kohlmann O, Ryan TJ, et al. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the reninangiotensin system and sympathetic nervous system. Journal of the American College of Cardiology 7: 758–765, 1986

    PubMed  CAS  Google Scholar 

  • Crozier IG, Ikram H, Nicholls MG, Jans S. Global and regional hemodynamic effects of ramipril in congestive heart failure. Journal of Cardiovascular Pharmacology 14: 688–693, 1989

    PubMed  CAS  Google Scholar 

  • Curtis C, Cohn JN, Vrobel T, Franciosa JA. Role of the reninangiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 58: 763–769, 1978

    Google Scholar 

  • Dall JLC. Maintenance digoxin in elderly patients. British Medical Journal 2: 705–706, 1970

    PubMed  CAS  Google Scholar 

  • Davidson C, Gibson D. Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease. British Heart Journal 35: 970–976, 1973

    PubMed  CAS  Google Scholar 

  • Davies RF, Bearlands DS, Nadeau C, et al. Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Journal of the American College of Cardiology 18: 1602–1609, 1991

    PubMed  CAS  Google Scholar 

  • Davis R, Ribner HS, Keung E, Sonnenblick EH, LeJemtel TH. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. New England Journal of Medicine 301: 117–121, 1979

    PubMed  CAS  Google Scholar 

  • DeMots H, Kremkau EL, Mahler D, Bennett W. Volumetric, metabolic and hemodynamic effects of ouabain in patients with coronary disease. Circulation 48 (Suppl. 4): 19, 1973

    Google Scholar 

  • DeMots H, Rahimtoola SH, McAnulty JH, Porter GA. Effects of ouabain on coronary systemic vascular resistance and myocardial oxygen consumption in patients without heart failure. American Journal of Cardiology 41: 88–93, 1978

    PubMed  CAS  Google Scholar 

  • DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. New England Journal of Medicine 320: 677–683, 1989

    PubMed  CAS  Google Scholar 

  • Dobbs SM, Kenyon WI, Dobbs RJ. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. British Medical Journal 1: 749–752, 1977

    PubMed  CAS  Google Scholar 

  • Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, et al. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 79: 491–502, 1989

    PubMed  CAS  Google Scholar 

  • Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, et al. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. New England Journal of Medicine 302: 1373–1379, 1980

    PubMed  CAS  Google Scholar 

  • Elfellah MS, Ogilvie RI. Effect of vasodilator drugs on coronary occlusion and reperfusion arrhythmias in anaesthesized dogs. Journal of Cardiovascular Pharmacology 7: 826–832, 1985

    PubMed  CAS  Google Scholar 

  • Ertl G, Kloner RA, Alexander RW, Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 65: 40–48, 1982

    PubMed  CAS  Google Scholar 

  • Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, et al. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 80: 65–77, 1989

    PubMed  CAS  Google Scholar 

  • Fleg JL, Gottlieb SH, Lakatta EG. Is digoxin really important in the treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. American Journal of Medicine 73: 244–250, 1982

    PubMed  CAS  Google Scholar 

  • Fowler MB, Alderman EL, Oesterle SN, Derby G, Daughters G, et al. Dobutamine and dopamine after cardiac surgery: greater augmentation of cardiac flow with dobutamine. Circulation 70 (Suppl. 1): 103–111, 1984

    Google Scholar 

  • Fowler NO, Holmes JC. Coronary and myocardial actions of angiotensin. Circulation Research 14: 191–201, 1964

    PubMed  CAS  Google Scholar 

  • Furberg CD, Yusuf S. Effects of vasodilators on survival in chronic congestive heart failure. American Journal of Cardiology 55: 1110–1113, 1985

    PubMed  CAS  Google Scholar 

  • Gavras H, Faxon DP, Berkoben J, Brunner HR, Ryan TJ. Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation 58: 770–776, 1978

    PubMed  CAS  Google Scholar 

  • Gavras H, Flessas A, Ryan TJ, Brunner HR, Faxon DP, et al. Angiotensin II inhibition: treatment of congestive failure in a high-renin hypertension. Journal of the American Medical Association 238: 880–882, 1977

    PubMed  CAS  Google Scholar 

  • Gavras H, Kremer D, Brown JJ, Gray B, Lever AF, et al. Angiotensin and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. American Heart Journal 89: 321–332, 1975

    PubMed  CAS  Google Scholar 

  • Gay RG. Early and late effects of captopril treatment after large myocardial infarction in rats. Journal of the American College of Cardiology 16: 967–977, 1990

    PubMed  CAS  Google Scholar 

  • German and Austrian Xamoterol Study Group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1: 489–493, 1988

    Google Scholar 

  • Gheorghiade M, Hall V, Lakier JB, Goldstein S. Comparative haemodynamic and neurohumeral effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. Journal of the American College of Cardiology 13: 134–142, 1989

    PubMed  CAS  Google Scholar 

  • Gheorghiade M, St Clair J, St Clair C, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. Journal of the American College of Cardiology 9: 849–857, 1987

    PubMed  CAS  Google Scholar 

  • Goldstein RA, Passamani ER, Roberts R. A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. New England Journal of Medicine 303: 846–850, 1980

    PubMed  CAS  Google Scholar 

  • Guyatt GH, Sullivan MJJ, Fallen EL, Tihal H, Rideout E, et al. A controlled trial of digoxin in congestive heart failure. American Journal of Cardiology 61: 371–375, 1988

    PubMed  CAS  Google Scholar 

  • Hodges M, Friesinger GC, Riggins RCK, Dagenais GR. Effects of intravenously administered digoxin on mild left ventricular failure in acute myocardial infarction in man. American Journal of Cardiology 29: 749–756, 1972

    PubMed  CAS  Google Scholar 

  • Hull SM. Discontinuation of maintenance digoxin therapy in general practice. Lancet 2: 1054–1055, 1977

    PubMed  CAS  Google Scholar 

  • Ikram H, Chan W, Espiner EA, Nicholls MG. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clinical Science 59: 443–449, 1980

    PubMed  CAS  Google Scholar 

  • Johnson GD, McDevitt DG. Is maintenance digoxin necessary in patients m sinus rhythm? Lancet 1: 567.-570, 1979

    Google Scholar 

  • Khairallah PA, Sen S, Tarazi RC. Angiotensin, protein biosynthesis and cardiovascular hypertrophy. American Journal of Cardiology 37: 148, 1976

    Google Scholar 

  • Kleber FX, Laube A, Osterkorn K, Konig E. Captopril in mild to moderate heart failure over 18 months; effects on morbidity and mortality. Journal of the American College of Cardiology 9: 42A, 1987

    Google Scholar 

  • Kleiman JH, Ingels NB, Daughters G, Stinson EB, Alderman EL, et al. Left ventricular dynamics during long term digoxin treatment in patients with stable coronary artery disease. American Journal of Cardiology 41: 937–942, 1978

    PubMed  CAS  Google Scholar 

  • Kumar R, Hood WB, Joison J, Gilmour DP, Norman JC, et al. Experimental myocardial infarction. VI. Efficacy and toxicity of digitalis in acute and healing phase in intact conscious dogs. Journal of Clinical Investigation 49: 358–364, 1970

    PubMed  CAS  Google Scholar 

  • Lambert H, Meyer J, Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation 69: 298–305, 1984

    Google Scholar 

  • Lee DC, Johnson RA, Bingham JB, Leahy M, Dinsmore RE, et al. Heart failure in outpatients. A randomised trial of digoxin versus placebo. New England Journal of Medicine 306: 699–705, 1982

    PubMed  CAS  Google Scholar 

  • Linz W, Scholkens BA, Han. Y. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischaemic rat hearts. Journal of Cardiovascular Pharmacology 8 (Suppl. 10): 91–99, 1986

    Google Scholar 

  • Lipp H, Denes P, Gambetta M, Resnekov L. Hemodynamic response to acute intravenous digoxin in patients with recent myocardial infarction and coronary insufficiency with and without heart failure. Chest 63: 862–867, 1973

    PubMed  CAS  Google Scholar 

  • Lipkin DP, Frennaux M, Maseri A. Beneficial effects of captopril in cardiogenic shock. Lancet 2: 327, 1987

    PubMed  CAS  Google Scholar 

  • Lown B, Klein MD, Barr I, Hagemeijer F, Kosowski BD, et al. Sensitivity to digitalis drugs in acute myocardial infarction. American Journal of Cardiology 30: 388–395, 1972

    PubMed  CAS  Google Scholar 

  • MacKenzie J, Orr J. Principles of diagnosis and treatment in heart conditions, 2nd ed., pp. 195–198, Oxford Medical, London, 1923

    Google Scholar 

  • Madsen EB, Gilpin E, Henning H, Ahnve S, LeWinter M, et al. Prognostic importance of digitalis after acute myocardial infarction. Journal of the American College of Cardiology 3: 681–689, 1984

    PubMed  CAS  Google Scholar 

  • Mancini DM, Davis L, Wexler JP, Chadwick B, LeJemtel TH. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. Journal of the American College of Cardiology 10: 845–850, 1987

    PubMed  CAS  Google Scholar 

  • Maroko PR, Braunwald E. Modification of myocardial infarction size after coronary occlusion. Annals of Internal Medicine 79: 720–733, 1973

    PubMed  CAS  Google Scholar 

  • McAlpine HM, Morton JJ, Leckie B, Dargie HJ. Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction. Journal of Cardiovascular Pharmacology 9 (Suppl. 2): 25–30, 1987

    Google Scholar 

  • McAlpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, et al. Neuroendocrine activation after acute myocardial infarction. British Heart Journal 60: 117–124, 1988

    PubMed  CAS  Google Scholar 

  • McHaffie D, Purcell H, Mitchell-Heggs P, Guz A. The clinical value of digoxin in patients with heart failure and sinus rhythm. Quarterly Journal of Medicine 47: 401–419, 1978

    PubMed  CAS  Google Scholar 

  • Michel JB. Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure. European Heart Journal 11 (Suppl. D): 17–26, 1990

    PubMed  CAS  Google Scholar 

  • Morris JJ, Taft CV, Whalen RE, McIntosh HD. Digitalis and experimental myocardial infarction. American Heart Journal 77: 342–355, 1969

    PubMed  CAS  Google Scholar 

  • Morrison J, Coromilas J, Robbins M, Ong L, Eisenberg S, et al. Digitalis and myocardial infarction in man. Circulation 62: 8–16, 1980

    PubMed  CAS  Google Scholar 

  • Moss AJ, Davis HT, Conard DL, DeCamilla JJ, Odoroff CL. Digitalis-associated cardiac mortality after myocardial infarction. Circulation 64: 1150–1156, 1981

    PubMed  CAS  Google Scholar 

  • Muiesan ML, Agabiti-Rosei E, Romanelli G, Castello M, Beschi M, et al. Beneficial effects of one year’s treatment with captopril on left ventricular anatomy and function in hypertensive patients with left ventricular hypertrophyy. American Journal of Medicine 84 (Suppl. 3A): 129–132, 1988

    PubMed  CAS  Google Scholar 

  • Muller JE, Turi ZG, Stone PH, Rude RE, Raabe DS, et al. Digoxin therapy and mortality after myocardial infarction. Experience of the MILIS study. New England Journal of Medicine 314: 265–271, 1986

    PubMed  CAS  Google Scholar 

  • Mulligan IP, Fraser AG, Lewis MJ, Henderson AH. Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure. British Heart Journal 61: 23–28, 1989

    PubMed  CAS  Google Scholar 

  • O’Rourke RA, Henning H, Theroux P, Crawford MH, Ross J. Favourable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction. American Journal of Cardiology 37: 708–715, 1976

    PubMed  Google Scholar 

  • Packer M, Lee WH, Medina N, Yushak M, Kessler PD. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Annals of Internal Medicine 106: 346–354, 1987

    PubMed  CAS  Google Scholar 

  • Packer M, Medina N, Yushak M. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe heart failure. Circulation 70: 1038–1047, 1984

    PubMed  CAS  Google Scholar 

  • Packer M, Medina N, Yushak M, Meller J. Hemodynamic patterns of response during long-term therapy for severe chronic heart failure. Circulation 68: 803–812, 1983

    PubMed  CAS  Google Scholar 

  • Packer M, Meller J, Gorlin R, Herman MV. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe congestive heart failure. Circulation 59: 531–539, 1979

    PubMed  CAS  Google Scholar 

  • Packer M, Meller J, Medina N, Yushak M. Quantitative differences in the hemodynamic effects of captopril and nitro-prusside in severe chronic heart failure. American Journal of Cardiology 51: 183–188, 1983

    PubMed  CAS  Google Scholar 

  • Paulson OB, Jarden JO, Godtfredsen J, Vorstrup S. Cerebral blood flow in patients with congestive heart failure treated with captopril. American Journal of Medicine 76 (Suppl. 5B): l9–98, 1984

    Google Scholar 

  • Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circulation Research 57: 84–95, 1985

    PubMed  CAS  Google Scholar 

  • Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long term therapy with captopril. Circulation 72: 406–412, 1985

    PubMed  CAS  Google Scholar 

  • Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. New England Journal of Medicine 319: 80–86, 1988

    PubMed  CAS  Google Scholar 

  • Pozen RG, DiBianco R, Katz RJ, Bortz R, Myerburg RJ, et al. Myocardial metabolic and haemodynamic effects of dobutamine in heart failure complicating coronary artery disease. Circulation 63: 1279–1285, 1981

    PubMed  CAS  Google Scholar 

  • Pugh SE, White NJ, Grahame-Smith DG, Bloomfield JG. Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term therapy. British Heart Journal 61: 529–539, 1989

    PubMed  CAS  Google Scholar 

  • Rahimtoola SH, Sinno MZ, Chuquima R, Loeb HS, Rosen KM, et al. Effects of ouabain on impaired left ventricular function in acute myocardial infarction. New England Journal of Medicine 287: 527–531, 1972

    PubMed  CAS  Google Scholar 

  • Richardson A, Bayliss J, Scriven AJ, Parameshwar J, Poole-Wilson PA, et al. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet 2: 709–711, 1987

    PubMed  CAS  Google Scholar 

  • Ryan TJ, Bailey KR, McCabe CH, Luk S, Fisher LD, et al. The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS). Circulation 67: 735–742, 1983

    PubMed  CAS  Google Scholar 

  • Schemm FR. Digitalis in cardiac disease without congestive heart failure or auricular fibrillation. Postgraduate Medical Journal 7: 385–390, 1950

    CAS  Google Scholar 

  • Schinz A, Schelle K, Klein G, Blomer H. Time sequence of direct vascular and inotropic effects following intravenous administration of digoxin in normal man. International Journal of Clinical Pharmacology Research 15: 189–196, 1977

    CAS  Google Scholar 

  • Sharpe DN, Douglas JE, Coxon RJ, Long B. Low dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment. Lancet, 2: 1154–1157, 1980

    PubMed  CAS  Google Scholar 

  • Sharpe DN, Murphy J, Coxon R, Hannan SF. Enalapril in patients with chronic heart failure: a placebo controlled, randomised, double-blind study. Circulation 70: 271–278, 1984

    PubMed  CAS  Google Scholar 

  • Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1: 255–259, 1988

    PubMed  CAS  Google Scholar 

  • Sjogren A. Left heart failure in acute myocardial infarction. III. The early haemodynamic effects of ouabain and frusemide in patients with acute myocardial infarction and raised pulmonary artery diastolic pressures. Acta Medica Scandinavica 510 (Suppl.): 53–55, 1970

    Google Scholar 

  • SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection and congestive heart failure. New England Journal of Medicine 325: 293–302, 1991

    Google Scholar 

  • Taggart AJ, Johnson GD, McDevitt DG. Digoxin withdrawal after cardiac failure in patients with sinus rhythm. Journal of Cardiovascular Pharmacology 5: 229–234, 1983

    PubMed  CAS  Google Scholar 

  • Taylor SH, Verma SP, Silke B. Enalaprilat in heart failure complicating acute myocardial infarction. Current Opinion in Cardiology 4(Suppl. 2): 37–43, 1989

    Google Scholar 

  • Turini GA, Brunner HR, Gribic M, Waeber B, Gavras H. Improvement of chronic congestive heart-failure by oral captopril. Lancet 1: 1213–1215, 1979

    PubMed  CAS  Google Scholar 

  • Varonkov Y, Shell WE, Smirnov V, Gukovsky D, Chazov EI. Augmentation of serum CPK activity by digitalis in patients with acute myocardial infarction. Circulation 55: 719–727, 1977

    PubMed  CAS  Google Scholar 

  • Vatner SF, Braunwald E. Effects of chronic heart failure on the inotropic response of the right ventricle of the conscious dog to a cardiac glycoside and to tachycardia. Circulation 50: 728–734, 1974

    PubMed  CAS  Google Scholar 

  • Vatner SF, Higgins CB, Franklin D, Braunwald E. Effects of a digitalis glycoside on coronary and systemic dynamics in conscious dogs. Circulation Research 28: 470–479, 1971

    PubMed  CAS  Google Scholar 

  • Webster MWI, Fitzpatrick MA, Nicholls MG, Ikram H, Wells JE. Effect of enalapril on ventricular arrhythmias in congestive heart failure. American Journal of Cardiology 56: 566–569, 1985

    PubMed  CAS  Google Scholar 

  • Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 77 (Suppl. 1): 30–39, 1988

    Google Scholar 

  • Withering W. An account of the foxglove, and some of its medical uses: with practical remarks on dropsy, and other diseases. CGJ and J Robinson, London 1785

  • Wood P. Heart Failure. In Somerville (Ed.) Diseases of the heart and circulation, 3rd ed. pp. 325–342, Eyre & Spottis-wood, London, 1968

  • Yusuf S, Wittes J, Bailey K, Furberg C. Digitalis — a new controversy regarding an old drug. The pitfalls of inappropriate methods. Circulation 73: 14–18, 1986

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Heart Foundation of New Zealand, Christchurch, New Zealand

    I. Crozier & H. Ikram

  2. Cardiology Department, The Princess Margaret Hospital, Canterbury Area Health Board, Private Bag, Christchurch, New Zealand

    I. Crozier & H. Ikram

Authors
  1. I. Crozier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Ikram
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crozier, I., Ikram, H. Angiotensin Converting Enzyme Inhibitors Versus Digoxin for the Treatment of Congestive Heart Failure. Drugs 43, 637–650 (1992). https://doi.org/10.2165/00003495-199243050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199243050-00002

Keywords

Search

Navigation